GFAP and Alzheimer disease: Additionally, plasma glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) have emerged as potential biomarkers for AD and other neurodegenerative diseases, further expanding the potential of blood‐based diagnostics.14